Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome

Soares, Elvira Maria Mafaldo; Azevedo, George Dantas de; Gadelha, Rafael G N; Lemos, Telma Maria Araújo Moura; Maranhão, Técia Maria de Oliveira

doi:10.1016/j.fertnstert.2007.03.081

Cited by 79 publications

(66 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Soares and cols. (15) reported in Brazilian women with PCOS, the prevalence of MS increased with advancing age. The cause of age related insulin resistance, however, remains unknown, Boden and cols.…”

Section: Discussionmentioning

confidence: 79%

“…The association between the prevalence of the MS and BMI was shown in normal population (29) and PCOS patients (15,25). Ehrmann and cols.…”

Section: Discussionmentioning

confidence: 96%

“…Many of the metabolic abnormalities of PCOS patients overlap with components of MS. The prevalence rates of MS in PCOS women vary among different countries and ethnicities as follows: 43-46% in America (11,12), 37.9% in India (13), 35.3% in Thailand (14), 28.4% in Brazil (15), 16.8% in China (16), 14.5% in Korea (17), 11.6% in Turkey (18) and 8.2% in Southern Italy (19). These differences in prevalence rates of MS in PCOS patients in different countries may be depended to several factors, like age, BMI, and race of patients as well as different approaches to define MS and PCOS.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Metabolic syndrome in infertile women with polycystic ovarian syndrome

Madani

Hosseini

Ramezanali

et al. 2016

Arch. Endocrinol. Metab.

View full text Add to dashboard Cite

Objective: The aim of the present study was to determine the prevalence of metabolic syndrome (MS) in infertile Iranian women with polycystic ovary syndrome (PCOS) using the ATPIII criteria. Subjects and methods: In this cross-sectional study, 624 women with PCOS were enrolled at a tertiary referral center in Tehran, Iran, between April, 2012 and March, 2013. Diagnosis of MS was according to ATPIII criteria. Also, we divided PCOS patients into following two main groups: (i) with MS (n = 123) and (ii) without MS (n = 501), and then compared variables between two groups. Results: The mean age, body mass index (BMI) and waist circumference were 28.6 ± 4.3 years, 26.7 ± 3.7 kg/m 2 and 85.2 ± 8.7 cm, respectively. The prevalence of MS was 19.7%. Our findings showed that age, BMI, waist circumference and all metabolic parameters were higher in PCOS women with MS than related values in those without MS. The most and least prevalent forms of MS were low level of high density lipoprotein-cholesterol (HDL-C) and hypertension, respectively. Conclusion: It seems the prevalence of metabolic syndrome in our country isn't as high as western countries. The prevalence rate of MS increased with age and BMI. One of the major cardiovascular risk factors, low level of HDL-C, is the most prevalent metabolic abnormality in our participants.

show abstract

Section: Discussionmentioning

confidence: 79%

“…The association between the prevalence of the MS and BMI was shown in normal population (29) and PCOS patients (15,25). Ehrmann and cols.…”

Section: Discussionmentioning

confidence: 96%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Metabolic syndrome in infertile women with polycystic ovarian syndrome

Madani

Hosseini

Ramezanali

et al. 2016

Arch. Endocrinol. Metab.

View full text Add to dashboard Cite

show abstract

“…This PCOS-MS overlap is not singularly met in Caucasian women with PCOS. A highly prevalent MS has also been identified in Brazilian, Chinese, Korean, Indian and in multiracial PCOS populations, at least in overweight/obese patients, in spite of the fact that there are variations in the MS prevalence rates dependent on ethnic/racial regions, age, the diagnostic criteria and the comparison group studied (Fig.1) (Soares et al, 2008;Cheung et al, 2008;Park et al, 2007;Bhattacharya, 2008;Glueck et al, 2003;Apridonidze et al, 2005;Ehrmann et al, 2006;Dokras et al, 2005). Data are presented as %.…”

Section: Metabolic Syndrome In Pcosmentioning

confidence: 99%

The Polycystic Ovary Syndrome Status - A Risk Factor for Future Cardiovascular Disease

Ilie¹,

Ilie²,

Mocan³

et al. 2012

Recent Advances in Cardiovascular Risk Factors

View full text Add to dashboard Cite

“…Além das características específicas que definem a síndrome, a SOP é reconhecida por estar associada a um conjunto de fatores de risco para doença cardiovascular (DCV), destacando-se dislipidemia (3), diabetes tipo 2 (4), obesidade central (5) e síndrome metabólica (6), com a participação da resistência à insulina (RI) como agente de integração dessas diversas anormalidades cardiometabólicas (7).…”

unclassified

Avaliação do risco cardiovascular por meio do índice LAP em pacientes não obesas com síndrome dos ovários policísticos

Costa

Sá

Soares

et al. 2010

Arq Bras Endocrinol Metab

Self Cite

View full text Add to dashboard Cite

RESUMOObjetivo: Analisar o risco cardiovascular de mulheres não obesas com síndrome dos ovários policísticos (SOP) por meio do índice LAP (lipid accumulation product). Sujeitos e métodos: 283 pacientes (18-34 anos) alocadas do Hospital Universitário da Universidade Federal do Rio Grande do Norte, Natal-RN, foram divididas em quatro grupos: 1) SOP magras (n = 35); 2) saudáveis magras (n = 162); 3) SOP com sobrepeso (n = 28); 4) saudáveis com sobrepeso (n = 58). The percentage of women above the 75th percentile of the LAP index was also higher in the subgroups with PCOS: lean (17.1 vs. 6.8%; p = 0.04); overweight (37.5 vs. 13.8%; p = 0.01). Conclusions: In our sample, patients with PCOS showed higher cardiovascular risk assessed by the LAP index in relation to healthy women, even in the absence of obesity. Arq Bras Endocrinol Metab. 2010;54 (7) InTRODUçãO A síndrome dos ovários policísticos (SOP) é uma desordem endócrina que pode estar presente em até 5% a 10% das mulheres em idade reprodutiva (1). Seu diagnóstico é firmado na presença de dois dos três fatores seguintes: anovulação crônica; sinais clínicos e/ou bioquímicos de hiperandrogenismo; presença de padrão ultrassonográfico ovariano policístico (2).

show abstract

Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome

Abstract: Objective: To determine the prevalence of the metabolic syndrome (MetS) and its components in Brazilian women with polycystic ovary syndrome (PCOS

Cited by 79 publications

References 41 publications

Metabolic syndrome in infertile women with polycystic ovarian syndrome

Metabolic syndrome in infertile women with polycystic ovarian syndrome

The Polycystic Ovary Syndrome Status - A Risk Factor for Future Cardiovascular Disease

Avaliação do risco cardiovascular por meio do índice LAP em pacientes não obesas com síndrome dos ovários policísticos

Contact Info

Product

Resources

About